nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—epithelium—vaginal cancer	0.132	0.132	CbGeAlD
Plerixafor—CXCR4—uterine cervix—vaginal cancer	0.131	0.131	CbGeAlD
Plerixafor—CXCR4—urethra—vaginal cancer	0.12	0.12	CbGeAlD
Plerixafor—CXCR4—endometrium—vaginal cancer	0.118	0.118	CbGeAlD
Plerixafor—CXCR4—mammalian vulva—vaginal cancer	0.114	0.114	CbGeAlD
Plerixafor—CXCR4—uterus—vaginal cancer	0.109	0.109	CbGeAlD
Plerixafor—CXCR4—female reproductive system—vaginal cancer	0.098	0.098	CbGeAlD
Plerixafor—CXCR4—female gonad—vaginal cancer	0.0891	0.0891	CbGeAlD
Plerixafor—CXCR4—vagina—vaginal cancer	0.0886	0.0886	CbGeAlD
